Ingestible electronic devices could monitor physiological conditions or deliver drugs.
Researchers at MIT and Brigham and Women’s Hospital have designed and demonstrated a small voltaic cell that is sustained by the acidic fluids in the stomach. The system can generate enough power to run small sensors or drug delivery devices that can reside in the gastrointestinal tract for extended periods of time.
This type of power could offer a safer and lower-cost alternative to the traditional batteries now used to power such devices, the researchers say.
“We need to come up with ways to power these ingestible systems for a long time,” says Giovanni Traverso, a research affiliate at the Koch Institute for Integrative Cancer Research. “We see the GI tract as providing a really unique opportunity to house new systems for drug delivery and sensing, and fundamental to these systems is how they are powered.”
Traverso, who is also a gastroenterologist and biomedical engineer at Brigham and Women’s Hospital, is one of the senior authors of the study. The others are Robert Langer, the David H. Koch Institute Professor at MIT; and Anantha Chandrakasan, head of MIT’s Department of Electrical Engineering and Computer Science and the Vannevar Bush Professor of Electrical Engineering and Computer Science. MIT postdoc Phillip Nadeau is the lead author of the paper, which appears in the Feb. 6 issue of Nature Biomedical Engineering.
Sustained by acid
Traverso and Langer have previously built and tested many ingestible devices that can be used to sense physiological conditions such as temperature, heart rate, and breathing rate, or to deliver drugs to treat diseases such as malaria.
“This work could lead to a new generation of electronic ingestible pills that could someday enable novel ways of monitoring patient health and/or treating disease,” Langer says.
These devices are usually powered by small batteries, but conventional batteries self-discharge over time and pose a possible safety risk. To overcome those disadvantages, Langer and Traverso worked with Nadeau and Chandrakasan, who specialize in developing low-power electronics.
The research team took inspiration from a very simple type of voltaic cell known as a lemon battery, which consists of two electrodes — often a galvanized nail and a copper penny — stuck in a lemon. The citric acid in the lemon carries a small electric current between the two electrodes.
To replicate that strategy, the researchers attached zinc and copper electrodes to the surface of their ingestible sensor. The zinc emits ions into the acid in the stomach to power the voltaic circuit, generating enough energy to power a commercial temperature sensor and a 900-megahertz transmitter.
In tests in pigs, the devices took an average of six days to travel through the digestive tract. While in the stomach, the voltaic cell produced enough energy to power a temperature sensor and to wirelessly transmit the data to a base station located 2 meters away, with a signal sent every 12 seconds.
Once the device moved into the small intestine, which is less acidic than the stomach, the cell generated only about 1/100 of what it produced in the stomach. “But there’s still power there, which you could harvest over a longer period of time and use to transmit less frequent packets of information,” Traverso says.
“This paper reports an exciting and remarkably broad collection of advances in ‘ingestible’ electronics — from bioresorbable power supplies to energy efficient electronics, advanced sensors/actuators, and wireless communication systems,” says John Rogers, a professor of materials science and engineering at Northwestern University, who was not involved in the research. “These types of systems have great potential to address important clinical needs.”
The current prototype of the device is a cylinder about 40 millimeters long and 12 millimeters in diameter, but the researchers anticipate that they could make the capsule about one-third that size by building a customized integrated circuit that would carry the energy harvester, transmitter, and a small microprocessor.
“A big challenge in implantable medical devices involves managing energy generation, conversion, storage, and utilization. This work allows us to envision new medical devices where the body itself contributes to energy generation enabling a fully self-sustaining system,” Chandrakasan says.
Once the researchers miniaturize the device, they anticipate adding other types of sensors and developing it for applications such as long-term monitoring of vital signs.
“You could have a self-powered pill that would monitor your vital signs from inside for a couple of weeks, and you don’t even have to think about it. It just sits there making measurements and transmitting them to your phone,” Nadeau says.
Such devices could also be used for drug delivery. In this study, the researchers demonstrated that they could use the power generated by the voltaic cell to release drugs encapsulated by a gold film. This could be useful for situations in which doctors need to try out different dosages of a drug, such as medication for controlling blood pressure.
Receive an email update when we add a new INGESTIBLE SENSORS article.
The Latest on: Ingestible sensors
via Google News
The Latest on: Ingestible sensors
- Did you have your pill? US approves first pill that can be digitally tracked through the bodyon November 24, 2020 at 4:46 pm
The Abilify MyCite aripiprazole tablets - for treating schizophrenia and manic episodes - have an ingestible sensor embedded inside them that records that the medication has been taken ...
- Disposable Medical Device Sensors Market Size to Surpass US$ 5466.4 million By 2025on November 23, 2020 at 5:23 am
The global Disposable Medical Device Sensors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.6% in the forecast period of 2020 to 2025 and will ...
- 3 FDA-Approved Mobile Health Sensor Devices You Should Knowon November 22, 2020 at 4:00 pm
Like Propeller Health, Proteus also intends to improve disease self-management. In July 2012, it won FDA approval for a pill containing an ingestible sensor that communicates information to a wearable ...
- The etectRx Communications Platform for Ingestible and Implantable Sensorson November 18, 2020 at 4:00 pm
etectRx has developed the first communications technology platform designed, developed, and validated specifically for ingestible and implantable sensors. The platform includes communications ...
- FDA Approves World's First Pill with an Embedded Sensoron November 17, 2020 at 4:00 pm
Proteus' ingestible sensor consists of layers where an integrade circuit is sandwiched between layers of magnesium and copper and modulates the current produced by a electrochemical reaction. (Image ...
- The History of the Proteus Ingestible Sensoron November 15, 2020 at 4:00 pm
The ingestible sensor from Proteus Digital Health can be co-encapsulated with a drug capsule. To learn about the story behind the technology, MD+DI got in touch with George Savage, MD, chief medical ...
- Importance of Telemedicine and Telehealth in the Times of Corona – Ariztonon November 12, 2020 at 5:17 pm
IoT and AI are streamlining remote patient monitoring, electronic healthcare record systems, introducing tracked ingestible sensors, smart hospitals, and mhealth systems. mHealth application is ...
- Ingestible Capsule for Use in Medical Applicationson November 12, 2020 at 4:00 pm
He will join the MIT faculty in 2019. MIT researchers have designed an ingestible sensor that can lodge in the stomach for a few weeks and communicate wirelessly with an external device. (Image source ...
- Digital Medicine Can Diagnose and Treat What Ails Youon November 11, 2020 at 6:46 am
Detection aids can also take the form of ingestible, sensor-bearing pills, called microbioelectronic devices. Some are being developed to detect things such as cancerous DNA, gases emitted by gut ...
via Bing News